AstraZeneca Partners With AmoyDx On Companion Diagnostics For Lynparza
Executive Summary
Teaming again with the Shanghai biotech, AstraZeneca will seek assays that can be incorporated into companion diagnostics for Lynparza in prostate and breast cancer.